National Medical Products Administration: Convert three prescription drugs, including Qinghou Yan Granules, to over-the-counter drugs

2024-03-18

The National Medical Products Administration recently announced that according to the "Measures for the Classification Management of Prescription Drugs and Non prescription Drugs (Trial)" (formerly Order No. 10 of the National Medical Products Administration), after being organized by the National Medical Products Administration for verification and review, Qinghou Yan Granules, Gushen Heji, and Qingre Jiedu Tablets have been converted from prescription drugs to over-the-counter drugs. According to the data, the main functions of Qinghou Yan Granules are nourishing yin, clearing throat, and detoxifying. Used for sore throat caused by acute tonsillitis and pharyngitis; The main function of the Kidney Strengthening Formula is to warm the kidneys, assist yang, and strengthen the kidneys and nourish yin. Suitable for lethargy caused by kidney deficiency, lower back pain, shin soreness and knee weakness, chills in the limbs, and increased nocturia; The main function of Qingre Jiedu tablets is to clear heat and detoxify. Used for fever, redness, irritability, thirst, and sore throat caused by excessive heat and toxins; Influenza and upper respiratory tract infections show the above symptoms. The National Medical Products Administration stated that the relevant drug marketing license holders are required to file with the provincial drug regulatory department for the revision of the instructions in accordance with the "Drug Registration Management Measures" and other relevant regulations before December 11, 2024, and promptly notify relevant medical institutions, drug trading enterprises, and other units of the content of the revised instructions. Other contents of the instructions for over-the-counter drugs beyond those specified in the template shall be executed in accordance with the original approval certificate. If the drug label involves relevant content, it should be revised together. Drugs produced from the date of supplementary application filing shall not continue to use the original drug instructions. (Lai Xin She)

Edit:GuoGuo    Responsible editor:FangZhiYou

Source:people.cn

Special statement: if the pictures and texts reproduced or quoted on this site infringe your legitimate rights and interests, please contact this site, and this site will correct and delete them in time. For copyright issues and website cooperation, please contact through outlook new era email:lwxsd@liaowanghn.com

Return to list

Recommended Reading Change it

Links

Submission mailbox:lwxsd@liaowanghn.com Tel:020-817896455

粤ICP备19140089号 Copyright © 2019 by www.lwxsd.com.all rights reserved

>